Treatment options for extra-intestinal manifestations of inflammatory bowel disease vary, but remain limited for some

被引：0

作者：

Adis Medical Writers ^{[1
]}

机构：

[1] Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, Auckland

来源：

Drugs & Therapy Perspectives | 2013年 / 29卷 / 6期

关键词：

Inflammatory Bowel Disease; Primary Sclerosing Cholangitis; Inflammatory Bowel Disease Patient; Alemtuzumab; Natalizumab;

D O I：

10.1007/s40267-013-0037-9

中图分类号：

学科分类号：

摘要：

Extra-intestinal manifestations (EIMs) of inflammatory bowel disease can affect many different organ systems. Pharmacological treatment options include corticosteroids, anaesthetics, antiresorptives, immunosuppressants, immunomodulators and biological agents, depending on the individual manifestation. Although for some EIMs, treatment options remain limited to surgery or are not yet clear. Additional research is needed to establish other effective EIM therapies. © 2013 Springer International Publishing Switzerland.

引用

页码：166 / 170

页数：4

共 50 条

[31] The impact of biologic therapies on Extra-Intestinal Manifestations in Inflammatory Bowel Disease: a multicentre observational study
Ferretti, F.
Monico, M. C.
Cannatelli, R.
Lenti, M. V.
Di Sabatino, A.
Carmagnola, S.
Conforti, F.
Pastorelli, I.
Caprioli, F.
Bezzio, C.
Saibeni, S.
Mazza, S.
Vecchi, M.
Maconi, G.
Ardizzone, S.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S239 - S240
[32] Prevalence and Characteristics of Extra-intestinal Manifestations in a single cohort of Italian Patients with Inflammatory Bowel Disease
Marino, M.
Sigura, E.
Castagnaviz, E.
Dottor, F.
Colombo, A.
Solito, S.
Terrosu, G.
Buda, A.
Berretti, D.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1007 - 1007
[33] Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease
Karmiris, Konstantinos
Avgerinos, Anastasios
Tavernaraki, Aikaterini
Zeglinas, Christos
Karatzas, Pantelis
Koukouratos, Theodoros
Oikonomou, Konstantinos A.
Kostas, Athanasios
Zampeli, Evanthia
Papadopoulos, Vasileios
Theodoropoulou, Angeliki
Viazis, Nikos
Polymeros, Dimitrios
Michopoulos, Spyridon
Bamias, Giorgos
Kapsoritakis, Andreas
Karamanolis, Dimitrios G.
Mantzaris, Gerassimos J.
Tzathas, Charalampos
Koutroubakis, Ioannis E.
JOURNAL OF CROHNS & COLITIS, 2016, 10 (04): : 429 - 436
[34] THE IMPACT OF BIOLOGIC THERAPIES ON EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE OBSERVATIONAL STUDY
Ferretti, F.
Monico, M. C.
Cannatelli, R.
Carmagnola, S.
Maconi, G.
Ardizzone, S.
DIGESTIVE AND LIVER DISEASE, 2021, 53 : S130 - S130
[35] Rare, but Serious Extra-intestinal Complication of Inflammatory Bowel Disease
Russo, Steven
Kahloon, Arslan
Davis, Michael
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1168 - S1169
[36] COMPLICATIONS AND EXTRA-INTESTINAL PROBLEMS IN INFLAMMATORY BOWEL-DISEASE
SMITH, JN
WINSHIP, DH
MEDICAL CLINICS OF NORTH AMERICA, 1980, 64 (06) : 1161 - 1171
[37] Kidney Injuries as Extra-intestinal Manifestation of Inflammatory Bowel Disease
Ronsin, Charles
Le Berre, Catherine
Ville, Simon
JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 784 - 786
[38] The gut and the inflammatory bowel diseases inside-out: extra-intestinal manifestations
Ribaldone, Davide G.
Pellicano, Rinaldo
Actis, Giovanni C.
MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (04) : 309 - 318
[39] Lung injury as an extra-intestinal manifestation of inflammatory bowel disease
Park, Kyung Sik
KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (05): : 851 - 852
[40] Vedolizumab in Inflammatory Bowel Disease: A Retrospective Review of Clinical Efficacy, Extra-intestinal Manifestations and Adverse Reactions
Patel, Ravi J.
Grimes, Ian
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S317 - S318

← 1 2 3 4 5 →